Location: Stamford, CT
CIK: 0001920938 · Show all filings
Period: Q4 2022 (Next →)
Filing Date: Feb 14, 2023
Total Value: $2.984B (56.7% shares, 43.3% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | GUARDANT HEALTH INC | 250,022,000 | $157M | 5.3% | $0.63 | — | NOTE 11/1 | 40131MAB5 |
| — | NANOSTRING TECHNOLOGIES INC | 145,520,000 | $118M | 4.0% | $0.81 | — | NOTE 2.625% 3/0 | 63009RAD1 |
| — | NOVOCURE LTD | 131,834,000 | $118M | 3.9% | $0.89 | — | NOTE 11/0 | 67011XAB9 |
| — | EXACT SCIENCES CORP | 139,000,000 | $110M | 3.7% | $0.79 | — | NOTE 0.375% 3/0 | 30063PAC9 |
| — | ALPHATEC HLDGS INC | 112,250,000 | $103M | 3.5% | $0.92 | — | NOTE 0.750% 8/0 | 02081GAB8 |
| — | NEVRO CORP | 109,251,000 | $100M | 3.4% | $0.92 | — | NOTE 2.750% 4/0 | 64157FAC7 |
| GKOS | GLAUKOS CORP | 1,661,851 | $72.59M | 2.4% | $49.32 | 0.0% | COM | 377322102 |
| — | IVERIC BIO INC | 3,341,300 | $71.54M | 2.4% | $21.41 | — | COM | 46583P102 |
| BIIB | BIOGEN INC | 252,542 | $69.93M | 2.3% | $282.44 | 0.0% | COM | 09062X103 |
| PCVX | VAXCYTE INC | 1,362,278 | $65.32M | 2.2% | $39.24 | 0.0% | COM | 92243G108 |
| NTRA | NATERA INC | 1,621,012 | $65.12M | 2.2% | $41.20 | 0.0% | COM | 632307104 |
| — | BRIDGEBIO PHARMA INC | 141,500,000 | $63.67M | 2.1% | $0.45 | — | NOTE 2.500% 3/1 | 10806XAB8 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 3,469,674 | $63.5M | 2.1% | $17.62 | 0.0% | COM | 22663K107 |
| XENE | XENON PHARMACEUTICALS INC | 1,548,110 | $61.04M | 2.0% | $36.42 | 0.0% | COM | 98420N105 |
| ISRG | INTUITIVE SURGICAL INC | 223,120 | $59.2M | 2.0% | $243.83 | 0.0% | COM NEW | 46120E602 |
| — | DECIPHERA PHARMACEUTICALS IN | 3,271,513 | $53.62M | 1.8% | $16.39 | — | COM | 24344T101 |
| — | KARYOPHARM THERAPEUTICS INC | 65,976,000 | $49.37M | 1.7% | $0.75 | — | NOTE 3.000%10/1 | 48576UAA4 |
| — | IONIS PHARMACEUTICALS INC | 52,740,000 | $48.95M | 1.6% | $0.93 | — | NOTE 4/0 | 462222AD2 |
| — | NEVRO CORP | 1,192,298 | $47.22M | 1.6% | $39.60 | — | COM | 64157F103 |
| — | TRAVERE THERAPEUTICS INC | 50,536,000 | $46.65M | 1.6% | $0.92 | — | NOTE 2.500% 9/1 | 761299AB2 |
| IRTC | IRHYTHM TECHNOLOGIES INC | 497,667 | $46.62M | 1.6% | $108.84 | 0.0% | COM | 450056106 |
| ALGN | ALIGN TECHNOLOGY INC | 219,930 | $46.38M | 1.6% | $200.17 | 0.0% | COM | 016255101 |
| — | OUTSET MED INC | 1,704,552 | $44.01M | 1.5% | $25.82 | — | COM | 690145107 |
| — | AMYRIS INC | 137,850,000 | $43.25M | 1.4% | $0.31 | — | NOTE 1.500%11/1 | 03236MAJ0 |
| KIDS | ORTHOPEDIATRICS CORP | 1,044,699 | $41.51M | 1.4% | $41.66 | 0.0% | COM | 68752L100 |
| — | EXACT SCIENCES CORP | 48,300,000 | $40.09M | 1.3% | $0.83 | — | NOTE 0.375% 3/1 | 30063PAB1 |
| ACRS | ACLARIS THERAPEUTICS INC | 2,393,985 | $37.71M | 1.3% | $16.09 | 0.0% | COM | 00461U105 |
| — | INSMED INC | 399,630,000 | $37.67M | 1.3% | $0.09 | — | NOTE 1.750% 1/1 | 457669AA7 |
| — | NEOGENOMICS INC | 43,000,000 | $36.47M | 1.2% | $0.85 | — | NOTE 1.250% 5/0 | 64049MAA8 |
| PEN | PENUMBRA INC | 162,828 | $36.22M | 1.2% | $195.51 | 0.0% | COM | 70975L107 |
| AMGN | AMGEN INC | 131,100 | $34.43M | 1.2% | $242.73 | 0.0% | COM | 031162100 |
| — | BELLUS HEALTH INC NEW | 4,112,494 | $33.8M | 1.1% | $8.22 | — | COM NEW | 07987C204 |
| — | IONIS PHARMACEUTICALS INC | 36,533,000 | $33.36M | 1.1% | $0.91 | — | NOTE 0.125%12/1 | 462222AB6 |
| LEGN | LEGEND BIOTECH CORP | 658,101 | $32.85M | 1.1% | $49.92 | — | SPONSORED ADS | 52490G102 |
| — | NUVASIVE INC | 36,665,000 | $32.21M | 1.1% | $0.88 | — | NOTE 0.375% 3/1 | 670704AJ4 |
| — | NEOGENOMICS INC | 48,678,000 | $31.95M | 1.1% | $0.66 | — | NOTE 0.250% 1/1 | 64049MAB6 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,242,802 | $31.63M | 1.1% | $23.32 | 0.0% | COM | 87164F105 |
| — | MERUS N V | 1,998,084 | $30.91M | 1.0% | $15.47 | — | COM | N5749R100 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,455,585 | $30.61M | 1.0% | $21.19 | 0.0% | COM | 89422G107 |
| — | TRAVERE THERAPEUTICS INC | 31,350,000 | $28.69M | 1.0% | $0.92 | — | NOTE 2.250% 3/0 | 89422GAA5 |
| KRYS | KRYSTAL BIOTECH INC | 358,056 | $28.37M | 1.0% | $74.22 | 0.0% | COM | 501147102 |
| — | HILLEVAX INC | 1,620,216 | $27.11M | 0.9% | $16.73 | — | COM | 43157M102 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 1,246,539 | $26.83M | 0.9% | $20.51 | 0.0% | COM | 23954D109 |
| — | DICE THERAPEUTICS INC | 839,075 | $26.18M | 0.9% | $31.20 | — | COM | 23345J104 |
| QDEL | QUIDELORTHO CORP | 300,437 | $25.74M | 0.9% | $84.70 | 0.0% | COM | 219798105 |
| GMED | GLOBUS MED INC | 343,626 | $25.52M | 0.9% | $68.09 | 0.0% | CL A | 379577208 |
| ACAD | ACADIA PHARMACEUTICALS INC | 1,493,121 | $23.77M | 0.8% | $15.63 | 0.0% | COM | 004225108 |
| ANAB | ANAPTYSBIO INC | 726,122 | $22.5M | 0.8% | $28.24 | 0.0% | COM | 032724106 |
| — | SILK RD MED INC | 416,817 | $22.03M | 0.7% | $52.85 | — | COM | 82710M100 |
| ESPR | ESPERION THERAPEUTICS INC NE | 3,393,405 | $21.14M | 0.7% | $7.15 | 0.0% | COM | 29664W105 |
| — | BIOMARIN PHARMACEUTICAL INC | 19,200,000 | $20.73M | 0.7% | $1.08 | — | NOTE 1.250% 5/1 | 09061GAK7 |
| APLS | APELLIS PHARMACEUTICALS INC | 389,596 | $20.15M | 0.7% | $53.04 | 0.0% | COM | 03753U106 |
| — | RAPT THERAPEUTICS INC | 1,000,000 | $19.8M | 0.7% | $19.80 | — | COM | 75382E109 |
| — | MIRATI THERAPEUTICS INC | 413,600 | $18.74M | 0.6% | $45.31 | — | COM | 60468T105 |
| TMDX | TRANSMEDICS GROUP INC | 303,185 | $18.71M | 0.6% | $53.15 | 0.0% | COM | 89377M109 |
| ARGX | ARGENX SE | 49,200 | $18.64M | 0.6% | $378.83 | — | SPONSORED ADR | 04016X101 |
| — | DBV TECHNOLOGIES S A | 12,107,785 | $18.52M | 0.6% | $1.53 | — | SPONSORED ADR | 23306J101 |
| SRPT | SAREPTA THERAPEUTICS INC | 140,352 | $18.19M | 0.6% | $115.88 | 0.0% | COM | 803607100 |
| REPL | REPLIMUNE GROUP INC | 662,349 | $18.02M | 0.6% | $20.78 | 0.0% | COM | 76029N106 |
| STE | STERIS PLC | 95,694 | $17.67M | 0.6% | $170.93 | 0.0% | SHS USD | G8473T100 |
| EW | EDWARDS LIFESCIENCES CORP | 235,319 | $17.56M | 0.6% | $77.07 | 0.0% | COM | 28176E108 |
| — | IMMUNOGEN INC | 3,474,497 | $17.23M | 0.6% | $4.96 | — | COM | 45253H101 |
| — | COOPER COS INC | 52,115 | $17.23M | 0.6% | $330.67 | — | COM NEW | 216648402 |
| — | INVITAE CORP | 21,500,000 | $17.04M | 0.6% | $0.79 | — | NOTE 2.000% 9/0 | 46185LAB9 |
| — | NUVASIVE INC | 16,500,000 | $16.23M | 0.5% | $0.98 | — | NOTE 1.000% 6/0 | 670704AL9 |
| — | BRIDGEBIO PHARMA INC | 42,294,000 | $16.15M | 0.5% | $0.38 | — | NOTE 2.250% 2/0 | 10806XAD4 |
| ENTA | ENANTA PHARMACEUTICALS INC | 325,838 | $15.16M | 0.5% | $45.59 | 0.0% | COM | 29251M106 |
| LUNG | PULMONX CORP | 1,621,494 | $13.67M | 0.5% | $9.51 | 0.0% | COM | 745848101 |
| — | MERSANA THERAPEUTICS INC | 1,862,700 | $10.92M | 0.4% | $5.86 | — | COM | 59045L106 |
| IMTX | IMMATICS N.V | 1,250,052 | $10.89M | 0.4% | $10.34 | 0.0% | SHS | N44445109 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 927,800 | $10.12M | 0.3% | $8.44 | 0.0% | COM | 74366E102 |
| — | BIOMARIN PHARMACEUTICAL INC | 9,000,000 | $9.574M | 0.3% | $1.06 | — | NOTE 0.599% 8/0 | 09061GAH4 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 313,403 | $9.155M | 0.3% | $23.04 | 0.0% | COM | 92790C104 |
| NKTX | NKARTA INC | 1,525,800 | $9.14M | 0.3% | $10.09 | 0.0% | COM | 65487U108 |
| CMPX | COMPASS THERAPEUTICS INC | 1,814,266 | $9.126M | 0.3% | $3.99 | 0.0% | COM | 20454B104 |
| DYN | DYNE THERAPEUTICS INC | 753,145 | $8.729M | 0.3% | $11.57 | 0.0% | COM | 26818M108 |
| — | INSMED INC | 10,000,000 | $8.3M | 0.3% | $0.83 | — | NOTE 0.750% 6/0 | 457669AB5 |
| NUVB | NUVATION BIO INC | 4,122,900 | $7.916M | 0.3% | $2.02 | 0.0% | COM CL A | 67080N101 |
| — | ALLAKOS INC | 920,304 | $7.749M | 0.3% | $8.42 | — | COM | 01671P100 |
| ALEC | ALECTOR INC | 725,024 | $6.692M | 0.2% | $8.72 | 0.0% | COM | 014442107 |
| KOD | KODIAK SCIENCES INC | 914,209 | $6.546M | 0.2% | $7.18 | 0.0% | COM | 50015M109 |
| — | SUPERNUS PHARMACEUTICALS | 6,500,000 | $6.419M | 0.2% | $0.99 | — | NOTE 0.625% 4/0 | 868459AD0 |
| — | FUSION PHARMACEUTICALS INC | 2,000,000 | $6.3M | 0.2% | $3.15 | — | COM | 36118A100 |
| MIST | MILESTONE PHARMACEUTICALS IN | 1,164,849 | $4.613M | 0.2% | $5.26 | 0.0% | COM | 59935V107 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 381,120 | $4.002M | 0.1% | $8.89 | 0.0% | CLASS A ORD | 61559X104 |
| ALXO | ALX ONCOLOGY HLDGS INC | 258,280 | $2.911M | 0.1% | $11.23 | 0.0% | COM | 00166B105 |
| — | NEKTAR THERAPEUTICS | 620,280 | $1.402M | 0.0% | $2.26 | — | COM | 640268108 |
| — | ITEOS THERAPEUTICS INC | 71,585 | $1.398M | 0.0% | $19.53 | — | COM | 46565G104 |